Welwaze Medical leverages science and technology to democratize and reduce the number of breast cancer death by early detection. The company’s ecosystem consists of Celbrea®, an FDA 510k cleared medical device that is disposable, easy-to-use, non-invasive and designed for women of any age and a companion app that uses AI to help women to monitor and manage their breast health with personalized recommendations.